Drug Shortage Report for ACT ESCITALOPRAM ODT

Last updated on 2020-02-21 History
Report ID 99974
Drug Identification Number 02454300
Brand name ACT ESCITALOPRAM ODT
Common or Proper name ACT ESCITALOPRAM 20MG OD TAB
Company Name ACTAVIS PHARMA COMPANY
Active Ingredient(s) ESCITALOPRAM
Strength(s) 20MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30UD
ATC code N06AB
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-02-29
Actual end date 2020-02-20
Shortage status Resolved
Updated date 2020-02-21
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2020-02-21 French Compare
v9 2020-02-21 English Compare
v8 2020-02-21 English Compare
v7 2020-01-30 French Compare
v6 2020-01-30 English Compare
v5 2020-01-09 French Compare
v4 2020-01-09 English Compare
v3 2019-11-29 English Compare
v2 2019-11-28 French Compare
v1 2019-11-28 English Compare